Application 201970
- Type
- ANDA
- Sponsor
- ORCHID HLTHCARE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RASAGILINE MESYLATE | RASAGILINE MESYLATE | TABLET;ORAL | EQ 0.5MG BASE | No | No |
| 002 | RASAGILINE MESYLATE | RASAGILINE MESYLATE | TABLET;ORAL | EQ 1MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 47781-138 | Rasagiline Mesylate | Rasagiline Mesylate | Alvogen, Inc. | ANDA | Current |
| 47781-138 | Rasagiline Mesylate | Rasagiline Mesylate | Alvogen, Inc. | ANDA | Current |
| 47781-139 | Rasagiline Mesylate | Rasagiline Mesylate | Alvogen, Inc. | ANDA | Current |
| 47781-139 | Rasagiline Mesylate | Rasagiline Mesylate | Alvogen, Inc. | ANDA | Current |
| 47781-683 | Rasagiline | Rasagiline | Alvogen, Inc. | ANDA | Current |
| 47781-683 | Rasagiline | Rasagiline | Alvogen, Inc. | ANDA | Current |
| 47781-683 | Rasagiline | Rasagiline | Alvogen, Inc. | ANDA | Current |
| 47781-683 | Rasagiline | Rasagiline | Alvogen, Inc. | ANDA | Current |
| 47781-690 | Rasagiline | Rasagiline | Alvogen, Inc. | ANDA | Current |
| 47781-690 | Rasagiline | Rasagiline | Alvogen, Inc. | ANDA | Current |
| 47781-690 | Rasagiline | Rasagiline | Alvogen, Inc. | ANDA | Current |
| 47781-690 | Rasagiline | Rasagiline | Alvogen, Inc. | ANDA | Current |